Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium

Citation
Bz. Atkins et al., Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium, J HEART LUN, 18(12), 1999, pp. 1173-1180
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF HEART AND LUNG TRANSPLANTATION
ISSN journal
10532498 → ACNP
Volume
18
Issue
12
Year of publication
1999
Pages
1173 - 1180
Database
ISI
SICI code
1053-2498(199912)18:12<1173:MCTIIV>2.0.ZU;2-4
Abstract
Background: Although cardiac transplantation is an ideal treatment for end- stage heart disease, inadequate donor availability has stimulated efforts t o manage terminally injured myocardium by other innovative methods. Autolog ous skeletal myoblast transplantation, or cellular cardiomyoplasty, is one method to potentially mediate myocardial repair within chronically injured hearts. However, few investigators have documented the ability of myogenic cells to alter load-insensitive indices of systolic and diastolic performan ce in vivo. In this study, both systolic and diastolic regional myocardial function were evaluated following left ventricular cryoinjury and compared with function after myogenic cell transplantation. Methods: Left ventricular pressure and segment length were determined in 9 rabbits by micromanometry and sonomicrometry 1 week following cryoinjury an d 3 weeks after myoblast transplantation. At study termination, the extent of myoblast engraftment was determined by histologic analysis. Systolic per formance was based on the linear regression of stroke work and end-diastoli c segment length. Diastolic properties were evaluated by the curvilinear re lationships between left ventricular pressure and strain, and left ventricu lar pressure and end-diastolic segment length. Results: Although mean indices of systolic performance were unchanged after cell transplantation, systolic performance improved in 3 animals. In contr ast, myoblast engraftment was associated with significantly improved diasto lic properties (strain and dynamic stiffness) in all animals. Conclusions: These data quantify temporal changes in regional myocardial pe rformance and suggest that cellular cardiomyoplasty improves diastolic comp liance prior to affecting systolic performance. Cellular cardiomyoplasty, a potential therapeutic-option for ischemic heart disease, appears to revers e diastolic creep and thus may represent a clinical alternative to transpla ntation in the near future.